Forge

Lewis & Clark Law School Debuts Innovative Litigation & Advocacy Skills Certificate to Forge Practiced Legal Advocates

by

Portland, Oregon – Lewis & Clark Law School has announced the launch of a cutting-edge certificate program focused on Litigation & Advocacy Skills, which is designed to cater to students aiming to master advocacy across various legal environments. This new initiative aims to equip participants with vital skills ranging from engaging in courtroom battles to excelling at negotiation tables. The program integrates intensive coursework with hands-on training and mentoring to create an immersive learning experience. It mandates that enrolled law students complete four foundational courses. Additionally, they must accrarily involve themselves in a minimum of … Read more

Jury Awards $495 Million in High-Stakes Baby Formula Lawsuit as Philadelphia Cases Forge New Legal Path

by

St. Louis, MO — A legal storm is brewing over claims that certain infant formulas may have toxic effects, with victims’ families securing a major victory in a $495 million verdict delivered by a St. Louis jury. This landmark decision underscores the rising tension and legal momentum as affected families seek justice for their infants’ alleged harm. Philadelphia, PA is also a key battleground, where multiple cases are on track for trial in the Court of Common Pleas. These lawsuits, however, are employing different legal strategies from those previously adjudicated, potentially setting a new precedent … Read more

Setback and Persistence: Zantac Cancer Lawsuits Forge Ahead Despite Federal Dismissals, Trials Continue in Various States

by

Philadelphia – In a recent turn of events in the Zantac litigation saga, Judge Joshua Roberts of the Philadelphia Court of Common Pleas has denied a motion for recusal brought by plaintiffs who pointed to a potential conflict of interest due to his wife’s position at the law firm Reed Smith. The firm represents Zantac manufacturer GlaxoSmithKline in jurisdictions outside of this case, sparking concerns of bias among litigants. The decision came amidst the broader context of numerous Zantac cases alleging that the drug, intended as a heartburn and ulcer remedy, contains unsafe levels of … Read more